We are looking for young people 2–17 years of age to join a Crohn’s disease (CD) research study to help us discover more about treating moderately to severely active IBD. If you are looking for a potential new treatment option for moderately to severely active IBD or ulcerative colitis (UC) (including associated symptoms such as chronic diarrhea, stomach pain, constant need to poop, weight loss and/or canker sores), consider one of our clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your child or teen 2–17 years of age may be eligible to take part.
Your child may be eligible to take part in the clinical trials if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Enrolling for a limited time.
